AtriCure, Inc. (ATRC)
NASDAQ: ATRC · IEX Real-Time Price · USD
23.37
+0.20 (0.86%)
Apr 29, 2024, 4:00 PM EDT - Market closed
AtriCure Employees
AtriCure had 1,050 employees on December 31, 2023. The number of employees did not change compared to the previous year.
Employees
1,050
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$380,233
Profits / Employee
-$28,989
Market Cap
1.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,050 | 0 | - |
Dec 31, 2022 | 1,050 | 175 | 20.00% |
Dec 31, 2021 | 875 | 125 | 16.67% |
Dec 31, 2020 | 750 | 20 | 2.74% |
Dec 31, 2019 | 730 | 110 | 17.74% |
Dec 31, 2018 | 620 | 50 | 8.77% |
Dec 31, 2017 | 570 | 70 | 14.00% |
Dec 31, 2016 | 500 | 70 | 16.28% |
Dec 31, 2015 | 430 | 110 | 34.38% |
Dec 31, 2014 | 320 | 0 | - |
Dec 31, 2013 | 320 | 90 | 39.13% |
Dec 31, 2012 | 230 | -10 | -4.17% |
Dec 31, 2011 | 240 | 20 | 9.09% |
Dec 31, 2010 | 220 | 20 | 10.00% |
Dec 31, 2009 | 200 | 0 | - |
Dec 31, 2008 | 200 | 0 | - |
Dec 31, 2007 | 200 | 24 | 13.64% |
Dec 31, 2006 | 176 | 16 | 10.00% |
Dec 31, 2005 | 160 | 87 | 119.18% |
Dec 31, 2004 | 73 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Phreesia | 1,438 |
Maravai LifeSciences Holdings | 650 |
Vir Biotechnology | 587 |
AbCellera Biologics | 586 |
Immatics | 535 |
Mirum Pharmaceuticals | 264 |
Prothena Corporation | 173 |
Scholar Rock Holding | 150 |
ATRC News
- 11 days ago - AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management - Business Wire
- 19 days ago - AtriCure to Announce First Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
- 2 months ago - AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results - Business Wire
- 3 months ago - AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference - Business Wire
- 4 months ago - AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024 - Business Wire
- 4 months ago - AtriCure Appoints Shlomi Nachman to the Board of Directors - Business Wire
- 4 months ago - AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - Business Wire